AU1143899A - Transdermal delivery of 3,4-diarylchromans - Google Patents

Transdermal delivery of 3,4-diarylchromans

Info

Publication number
AU1143899A
AU1143899A AU11438/99A AU1143899A AU1143899A AU 1143899 A AU1143899 A AU 1143899A AU 11438/99 A AU11438/99 A AU 11438/99A AU 1143899 A AU1143899 A AU 1143899A AU 1143899 A AU1143899 A AU 1143899A
Authority
AU
Australia
Prior art keywords
diarylchromans
transdermal delivery
transdermal
delivery
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU11438/99A
Inventor
Helle Weibel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
Original Assignee
Novo Nordisk AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk AS filed Critical Novo Nordisk AS
Publication of AU1143899A publication Critical patent/AU1143899A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
AU11438/99A 1997-11-10 1998-11-09 Transdermal delivery of 3,4-diarylchromans Abandoned AU1143899A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK1278/97 1997-11-10
DK127897 1997-11-10
PCT/DK1998/000481 WO1999024032A1 (en) 1997-11-10 1998-11-09 Transdermal delivery of 3,4-diarylchromans

Publications (1)

Publication Number Publication Date
AU1143899A true AU1143899A (en) 1999-05-31

Family

ID=8103049

Family Applications (1)

Application Number Title Priority Date Filing Date
AU11438/99A Abandoned AU1143899A (en) 1997-11-10 1998-11-09 Transdermal delivery of 3,4-diarylchromans

Country Status (3)

Country Link
EP (1) EP1028724A1 (en)
AU (1) AU1143899A (en)
WO (1) WO1999024032A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU770573B2 (en) * 1998-07-09 2004-02-26 Lts Lohmann Therapie-Systeme Ag Transdermal plaster containing at least one active ingredient which influences blood serum lipid levels

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI982733A (en) 1998-12-17 2000-06-18 Orion Yhtymae Oyj Soluble compositions of triphenylethylene estrogens
DK1201232T3 (en) * 1999-07-27 2007-08-13 Hisamitsu Pharmaceutical Co Patches for external use
GB0003310D0 (en) * 2000-02-15 2000-04-05 Univ Sheffield Bone formation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5451603A (en) * 1993-03-11 1995-09-19 Zymogenetics, Inc. 3,4-diarylchromans for treatment of dermatitis
US5280040A (en) * 1993-03-11 1994-01-18 Zymogenetics, Inc. Methods for reducing bone loss using centchroman derivatives
US5407955A (en) * 1994-02-18 1995-04-18 Eli Lilly And Company Methods for lowering serum cholesterol and inhibiting smooth muscle cell proliferation, restenosis, endometriosis, and uterine fibroid disease
TW448046B (en) * 1995-01-20 2001-08-01 Novo Nordisk As Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of obesity
BR9706966A (en) * 1996-01-11 1999-05-04 Novo Nordisk As Use of the 1-enanciomer of a compound and process for treatment or prophylaxis of breast cancer

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU770573B2 (en) * 1998-07-09 2004-02-26 Lts Lohmann Therapie-Systeme Ag Transdermal plaster containing at least one active ingredient which influences blood serum lipid levels

Also Published As

Publication number Publication date
WO1999024032A1 (en) 1999-05-20
EP1028724A1 (en) 2000-08-23

Similar Documents

Publication Publication Date Title
AU7077098A (en) Transdermal delivery system
AU6740298A (en) Pharmaceutical composition
AU7908098A (en) Biologically active 1,3-bis-aromatic-prop-2-en-1-ones, 1,3-bis-aromatic-propan-1-ones, and 1,3-bis-aromatic-prop-2-yn-1-ones
AU5387898A (en) Pharmaceutical agents
AU8495998A (en) Improved dosage units
AU7333398A (en) Nasal melatonin composition
AU9343098A (en) Pharmaceutical composition
AU8695298A (en) Compounds and uses thereof
AU7761498A (en) Algicides
AU1143899A (en) Transdermal delivery of 3,4-diarylchromans
AU5944898A (en) Catheter
AU6525998A (en) Improved metallo-endopeptidases
AU5490298A (en) Syringe
AU1171099A (en) Therapeutic agents
AU5093199A (en) Transdermal delivery system
AU1046799A (en) Compound, composition and use
AUPP003297A0 (en) 4,5-diaryloxazole compounds
AU7641098A (en) Therapeutic composition
AU6965398A (en) Preparation of thiazoles using 1,3-dihalopropenes
AU8693198A (en) Compounds and uses thereof
AU6958898A (en) Preparation of heterocycles using 1,3-dihalopropenes
AU9229598A (en) Transplacental delivery of oligonucleotides
AU1046299A (en) Compound, composition and use
AU1046399A (en) Compound, composition and use
AU1046499A (en) Compound, composition and use

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase